Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 6/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 5/20 | 0.42 |
| ▸ | ERAP1 | Q9NZ08 | 5/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 4/20 | 0.42 |
| ▸ | NPBWR1 | P48145 | 3/20 | 0.42 |
| ▸ | IL1RN | P18510 | 2/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.41 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12514972 | 0.97 | MC4R (0.46) | MC4RERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL13973857 | 0.97 | MC4R (0.46) | MC4RERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL13973759 | 0.97 | MC4R (0.46) | MC4RERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL13973837 | 0.97 | MC4R (0.46) | MC4RERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL19486139 | 0.96 | MC4R (0.45) | MC4RERAP2ERAP1LNPEPNPBWR1 | |
| SCHEMBL19219797 | 0.96 | MC4R (0.45) | MC4RERAP2ERAP1LNPEPNPBWR1 | |
| SCHEMBL13978375 | 0.95 | MC4R (0.47) | MC4RNPBWR1IL23RKISS1R | |
| SCHEMBL12515001 | 0.95 | MC4R (0.47) | MC4RNPBWR1IL23RKISS1R | |
| SCHEMBL12514982 | 0.95 | MC4R (0.47) | MC4RNPBWR1IL23RKISS1R | |
| SCHEMBL19214489 | 0.95 | MC4R (0.46) | MC4RERAP2ERAP1LNPEPNPBWR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011084970-A1 | ANTI-HEPARIN COMPOUNDS | POLYMEDIX INC. (US) | 2011-07-14 | — | — | WO | disclosed |